Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Merchants Bancorp C Pref | MBINN | Oct 11, 2024 | 23.80 | -0.61 |
Merchants Bancorp Pref D | MBINM | Oct 11, 2024 | 26.03 | +0.42 |
Merck & Co | MRK | Oct 11, 2024 | 109.73 | +0.30 |
Mercurity Fintech | MFH | Oct 11, 2024 | 1.79 | +7.19 |
Mercury General | MCY | Oct 11, 2024 | 65.06 | +0.43 |
Mercury Systems | MRCY | Oct 11, 2024 | 36.20 | +2.14 |
Mereo BioPharma ADR | MREO | Oct 11, 2024 | 4.34 | +5.34 |
Meridian | MRBK | Oct 11, 2024 | 12.92 | -0.23 |
MeridianLink | MLNK | Oct 11, 2024 | 20.73 | +1.97 |
Merit Medical Systems | MMSI | Oct 11, 2024 | 94.35 | +0.63 |
Meritage Homes | MTH | Oct 11, 2024 | 193.79 | +0.89 |
Merrill Lynch & Co. | IPB | Oct 11, 2024 | 26.49 | -0.78 |
Mersana Therapeutics | MRSN | Oct 11, 2024 | 1.97 | +3.68 |
Merus N.V | MRUS | Oct 11, 2024 | 53.40 | +1.48 |
Mesa Air Group | MESA | Oct 11, 2024 | 1.17 | -2.09 |
Mesa Laboratories | MLAB | Oct 11, 2024 | 126.18 | +3.02 |
Mesa Royalty Trust | MTR | Oct 11, 2024 | 6.12 | -1.61 |
Mesabi Royalty Trust | MSB | Oct 11, 2024 | 24.55 | +1.24 |
Mesoblast ADR | MESO | Oct 11, 2024 | 10.08 | +8.04 |
Meta Materials | MMAT | Oct 11, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Oct 11, 2024 | 589.95 | +1.05 |
Metagenomi | MGX | Oct 11, 2024 | 1.96 | +2.08 |
Metal Sky Star Acquisition | MSSA | Oct 11, 2024 | 11.38 | -0.18 |
Metalla Royalty & Streaming | MTA | Oct 11, 2024 | 3.60 | +0.56 |
Metallus | MTUS | Oct 11, 2024 | 14.88 | +1.92 |
Metals Acquisition | MTAL | Oct 11, 2024 | 12.97 | 0.00 |
Methalpa Technology Holding | MATH | Oct 11, 2024 | 1.15 | 0.00 |
Methanex | MEOH | Oct 11, 2024 | 42.13 | -1.84 |
Methode Electronics | MEI | Oct 11, 2024 | 10.97 | +5.48 |
MetLife | MET | Oct 11, 2024 | 85.51 | +1.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.